The three most frequent somatic mutations in HCC are TERT promoter activating mutations which are found in 40%−60% of HCC patients; and the mutually exclusive TP53 and CTNNB1 mutations which are found in 30–50% of HCC cases[47–49]. Here, TERT is linked to hepatocellular carcinoma.